CATB

Catabasis Pharmaceuticals, Inc. CATB

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CATB SLRN CELU THRD CBLI INXB MACK CRGX SPPI INZY
6M 0.00 % -27.94 % 27.70 % 53.71 % 0.00 % 13.94 % 14.39 % 17.63 % 31.75 % 177.78 %
YTD 0.00 % -31.21 % -14.09 % -51.27 % 0.00 % 13.94 % 13.79 % -70.30 % 167.97 % 40.35 %
1Y 0.00 % -42.96 % 11.83 % -60.15 % 252.18 % 13.94 % 21.55 % -81.53 % -10.87 % -31.03 %
3Y 0.00 % -87.39 % -91.89 % -68.35 % 56.93 % -90.67 % 136.64 % -69.24 % -75.65 % 17.99 %
5Y 0.00 % -87.39 % -98.16 % -68.35 % -2.46 % -90.67 % 240.34 % -69.24 % -95.47 % -79.54 %
10Y 0.00 % -87.39 % -98.07 % -68.35 % -90.73 % 1 486.00 % -74.80 % -69.24 % -86.62 % -77.19 %
From the beginning 0.00 % -87.39 % -98.07 % -68.35 % -97.01 % 1 486.00 % -68.13 % -69.24 % -99.25 % -77.19 %

Dividend

Third Harmonic Bio, Inc.

Merrimack Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.